GLP-1s May Quiet ‘Food Noise’
GLP-1 patients have been surprised to discover they no longer think about food as often—their “food noise” has decreased or disappeared.
Entries by Melanie Padgett Powers
Can GLP-1s Lower My Dementia Risk?
A two-year drug trial examining whether GLP-1s could slow progression of Alzheimer’s disease has shown disappointing results. The drug company Novo Nordisk’s EVOKE/EVOKE+ Phase 3 trial studied whether the drug semaglutide is safe and effective at treating mild cognitive impairment (MCI) due to Alzheimer’s disease. Semaglutide is a GLP-1 receptor agonist better known under its […]
Autism Starts in Your Genes
A Q&A with autism researcher Daniel Geschwind, MD, PhD, about how autism spectrum disorders start in early pregnancy.
How Our Memory Makes Mistakes—and How We Can Improve It
A Q&A with Daniel L. Schacter, PhD, about “The Seven Sins of Memory” and how past memories influence future memories too.
UsAgainstAlzheimer’s Tackles Alzheimer’s Disease Challenges
A Q&A with UsAgainstAlzheimer’s COO Russ Paulsen, about the funding fight, early detection and caregiving challenges.
Alzheimer’s Disease: New Drugs & Research Discoveries
Let’s explore what causes Alzheimer’s disease—and new drugs and promising research that can improve treatment.
Girls Are More at Risk for Concussions
Girls’ body type, physiology and other factors may increase concussion risk—and lead to a longer recovery.
6 Concussion Myths Debunked
Welcome to modern-day concussion treatment. Here are myths or old-school methods you should ignore.
Concussions: What Parents Should Know
Kids have the highest risk of concussion, but concussions are treatable—with a fast, accurate diagnosis.
Kindness Makes Us Happy
Each year the World Happiness Report reviews the state of happiness across the globe and examines differences in happiness.